The portfolio consists of products that are being divested by Teva as a precondition to its closing of the acquisition of Allergan's generics business, the Hyderabad-based firm said
Read MoreGovernment is considering a proposal to relax foreign direct investment norms in existing pharmaceutical companies with a view to attracting more overseas inflows
Read MoreSun Pharma has not only violated the good corporate governance in terms of transparency but also consciously tried to make the investors believe that there is no plan to either divest assets or to cut jobs by strongly denying the then true media reports
Read MoreThe world's fifth biggest generic drug maker launched a new dermatology product - Suncros - a sunscreen brand which was earlier available only as a branded prescription product
Read MoreCapping the price of a device is counter-productive - it will halt research and innovation and won't benefit the patient; the cost of the device such as stent is a mere fraction of the total cost of the procedure required for its implantation
Read MoreSun Pharma’s formulation sales in the United States at $580 million during the quarter grew 19 per cent over the last year
Read MoreThe drug controller general of India has granted limited approval to Stempeutics Research, a joint venture between drug maker Cipla and Manipal Group for manufacturing and marketing its stem cell based biological drug Stempeucel for the treatment of Buerger’s Disease
Read MoreThe DoJ's antitrust division has also asked Sun Pharma's US unit for documents related to employee and corporate records and communications with competitors
Read MoreDr Reddy's Laboratories said on Wednesday that it has acquired a range of consumer health or over-the-counter brands from the US-based Ducere Pharma Llc for an undisclosed sum
Read MoreCipla’s January-to-March quarter results were below the market expectation due to inventory write-offs or reductions, rationalisation of unviable geographies, higher research and development spends and regulatory costs
Read More